Search results
Lexicon's (LXRX) Inpefa Gets Preferred Status at Express Scripts
Zacks via Yahoo Finance UK· 9 months agoA pharmacy benefit manager decides to place Lexicon's (LXRX) heart failure drug as a preferred...
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
Fortune via Yahoo Finance UK· 3 weeks agoBiden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say...
Why indie pharmacies, with the help of the likes of Mark Cuban, are on the rise
Yahoo Finance· 1 year agoIndependent pharmacies and startups such as Cigna's Express Scripts and Mark Cuban's Cost Plus Drugs...
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care...
Fortune via Yahoo Finance UK· 4 months agoThe billionaire entrepreneur spoke to Fortune after participating in a White House roundtable...
Lexicon Pharma shares rise after Inpefa gets preferred status at Express Scripts
Investing.com via Yahoo Finance UK· 9 months agoInvesting.com -- Shares in Lexicon Pharmaceuticals (NASDAQ:LXRX) jumped in premarket U.S. trading on Tuesday, after the group said its heart failure drug had received preferred status at Express ...
Mark Cuban Cost Plus Drugs Company takes another step 'to disrupt the current pharmacy supply chain'
Yahoo Finance· 2 years agoThe Mark Cuban Cost Plus Drug Company is teaming up with EmsanaRx, a pharmacy benefit manager, to...
Raskin presses insurers, PBMs on free contraception coverage
The Hill via Yahoo News UK· 2 months agoThe top Democrat on the House Oversight and Accountability Committee wants to know how the country’s...
CVS drug plans will cover new OTC birth control pill for free
The Hill via Yahoo News UK· 3 months agoCVS prescription drug plans will cover the first nonprescription birth control pill in the U.S.,...
New AMA report calls for state regulation of drug price middlemen
Yahoo Finance· 2 years agoThe American Medical Association (AMA) released a new report Thursday that puts pharmacy benefits...
AbbVie trims forecast for Humira sales drop on favorable coverage
Reuters via Yahoo Finance UK· 11 months ago(Reuters) -AbbVie on Thursday trimmed its 2023 view for declining sales of its flagship arthritis...